10x Genomics, Inc. Class A Common Stock TXG
Analyst Ratings
- Consensus
- Hold — 5 Buy · 9 Hold · 0 Sell (14 analysts)
- Avg. Price Target
- $44.15 (-42.4% downside)
Key Stats
- Today's Range
- $75.21 – $78.08
- 50-Day Range
- $41.44 – $79.94
- 52-Week Range
- $11.16 – $79.94
- Volume
- 2.89 million shs
- Average Volume
- 3.04 million shs
- Market Cap
- $10.03 billion
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 12.15
- Price / Sales
- 16.26
Short Interest
- Short Interest
- 0.42%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- $616.91 million
- Net Income
- $-75,125,000
- Net Margin
- -12.18%
- Return on Equity
- -9.10%
- Debt-to-Equity
- —
About 10x Genomics, Inc. Class A Common Stock
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
Related Stocks
Compare head-to-head: TXG vs WAT·TXG vs BIO·TXG vs BRKR·TXG vs CTKB
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.